SARS-CoV-2 Pseudoviral Particles, Omicron XBB.1.16 Subtype
|
Catalog Number:
SCV2-PsV-XBB1.16
|
|
SARS-CoV-2 Pseudoviral Particles, replication-deficient MLV pseudotyped with the SARS-CoV-2 spike protein (the Omicron variant XBB.1.16 subtype). (Mobile users please click "View Full Site" for details).
Accepting pre-order now.
|
Detailed Description
Keyword: coronavirus, SARS, SARS-Cov, SARS-COV-2, covid19, covid-19, SARS pseudovirus, sars-cov-2 pseudovirus, sars-cov-2 spike, MLV, ace2, Omicron, Omicron variant
|
SCV2-PsV-XBB1.16
|
|
Name
|
SARS-CoV-2 Pseudoviral Particles, Omicron XBB.1.16 Subtype
|
|
Description
|
The SARS-CoV-2 Pseudoviral Particles are replication-deficient Maloneymurine leukemia virus (MLV or MuLV) pseudotyped with the SARS-CoV-2 spike protein carrying the Omircon XBB.1.16 subtype genotype (GISAID Accession # EPI_ISL_17525370).
Replication deficient MLV-based virus system is a good choice for making pseudoviral particles in regards of lab safety and product quality.
|
|
Applications
|
Our Pseudovirus Particles generate robust chemiluminescent signals in cell assays when coupled with our firefly luciferase assay kit (Catalog # CA-L165), useful for 1) screening potential inhibitors to block SARS-CoV-2 entry and viral protein; 2) measuring the activity of and screening for neutralizing antibody against SARS-CoV-2.
|
|
Size
|
5 ml, for one multi-well plate
|
|
Storage
|
-70oC. Shipped on dry ice.
|
|
Note
|
1. Amenable to HTS format (96-well, 384-well and 1536-well format).
2. HEK293-hACE2 stable cells are available seperately (Cat.# CL-hACE2-001, CL-hACE2-002)
|
|
For Downloading
|
==>> DATA SHEET ==>> SAFETY DATA SHEET
|
Selected Citation:
A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2–Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms 2024, 12(3), 501
|
|
|